GlycoMimetics Shares Are Trading Higher After the Company Disclosed That Chief Medical Officer Edwin Rock Bought 305,000 Shares at an Average Price of $0.26 per Share.
GlycoMimetics Shares Are Trading Higher After the Company Disclosed That Chief Medical Officer Edwin Rock Bought 305,000 Shares at an Average Price of $0.26 per Share.
glycomimetics股價上漲，在公司透露首席醫療官埃德溫·洛克以0.26美元的平均價格購買了305,000股後。
GlycoMimetics Shares Are Trading Higher After the Company Disclosed That Chief Medical Officer Edwin Rock Bought 305,000 Shares at an Average Price of $0.26 per Share.
glycomimetics股票交易價格上漲，公司披露首席醫療官埃德溫 · 羅克以0.26美元每股的平均價格購買了305,000股。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。